Drug intelligence / Profile preview

dexamethasone + doxycycline + nystatin + promethazine

Development stage
Unknown
Lead developer
The University of Faisalabad
Modality
Small Molecules
Administration
Topical
01

Overview

This combination therapy, developed and studied at the University of Faisalabad, is a multi-component "cocktail rinse" designed for the symptomatic management of oral lichen planus (OLP). The rinse contains dexamethasone (a corticosteroid), doxycycline (a tetracycline antibiotic), nystatin (an antifungal), and promethazine (an antihistamine). Dexamethasone provides potent anti-inflammatory action to resolve mucosal lesions. Doxycycline is included for its ability to inhibit matrix metalloproteinases, which contribute to tissue degradation in OLP. Nystatin serves as a prophylactic measure against oral candidiasis, a common side effect of topical steroid therapy. Promethazine is added for its sedative and local anesthetic properties to provide immediate pain relief. In clinical trials, this cocktail is typically evaluated as an adjunct to triamcinolone acetonide orabase.

Other names
Cocktail rinseUniversity of Faisalabad cocktail rinsedexamethasone-University of Faisalabad-oral lichen planus
02

Targets

MR (Mineralocorticoid receptor)HRH1 (Histamine H1 Receptor)Bacterial RibosomeMMP12 (Macrophage Metalloelastase)GR (Glucocorticoid receptor)Ergosterol

Beyond the preview

Go deeper on dexamethasone + doxycycline + nystatin + promethazine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexamethasone + doxycycline + nystatin + promethazine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call